Development of a novel, pan-variant aerosol intervention for COVID-19

To develop a universal strategy to block SARS-CoV-2 cellular entry and infection represents a central aim for effective COVID-19 therapy. The growing impact of emerging variants of concern increases the urgency for development of effective interventions. Since ACE2 is the critical SARS-CoV-2 recepto...

Descripción completa

Detalles Bibliográficos
Autores principales: Shoemaker, Robert H., Panettieri, Reynold A., Libutti, Steven K., Hochster, Howard S., Watts, Norman R., Wingfield, Paul T., Starkl, Philipp, Pimenov, Lisabeth, Gawish, Riem, Hladik, Anastasiya, Knapp, Sylvia, Boring, Daniel, White, Jonathan M., Lawrence, Quentin, Boone, Jeremy, Marshall, Jason D., Matthews, Rebecca L., Cholewa, Brian D., Richig, Jeffrey W., Chen, Ben T., McCormick, David L., Gugensberger, Romana, Höller, Sonja, Penninger, Josef M., Wirnsberger, Gerald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452093/
https://www.ncbi.nlm.nih.gov/pubmed/34545364
http://dx.doi.org/10.1101/2021.09.14.459961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452093/
https://www.ncbi.nlm.nih.gov/pubmed/34545364
http://dx.doi.org/10.1101/2021.09.14.459961

Ejemplares similares